| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear lamina | 5.83e-05 | 2 | 153 | 2 | GO:0160123 | |
| GeneOntologyCellularComponent | cytoplasmic region | SPAST DNAH10 CNTRL IQSEC2 DNAH2 GRIK2 GCK CFAP54 DNAH17 RIMS2 CCDC40 | 8.06e-05 | 360 | 155 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.01e-04 | 18 | 155 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | HULC complex | 3.25e-04 | 4 | 155 | 2 | GO:0033503 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT5 SPAST DNAH10 FBF1 DNAH2 GCK TEK CHMP2A FAM83H KRT75 LMNA LMNB1 MAP1LC3C TTLL11 DNAH17 TMOD1 CEP295 | 3.77e-04 | 899 | 155 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.15e-04 | 20 | 155 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | XY body | 6.35e-04 | 23 | 155 | 3 | GO:0001741 | |
| GeneOntologyCellularComponent | spindle | SPAST FBF1 CNTRL CHMP2A SPDL1 YEATS2 FRY MAD1L1 CEP295 ATM MAPKBP1 | 7.98e-04 | 471 | 155 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | lamin filament | 8.04e-04 | 6 | 155 | 2 | GO:0005638 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.16e-04 | 25 | 155 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | spindle pole | 8.61e-04 | 205 | 155 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | UBR2 SUPT3H PDE3B RAD18 FBF1 CNTRL LARS1 PSMC3 FAM98B ITPR1 YEATS2 UBE2A UBE2B MEGF8 ANAPC1 SYVN1 ZSWIM4 | 9.03e-04 | 972 | 155 | 17 | GO:0140535 |
| GeneOntologyCellularComponent | nuclear pore | 9.39e-04 | 101 | 155 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear envelope | DPY19L3 SPAST RGPD8 SYNE1 RGPD1 CHMP2A ITPR1 PARP6 LMNA LMNB1 MAD1L1 RGPD5 | 9.80e-04 | 560 | 155 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT5 SPAST DNAH10 SYNE1 FBF1 DNAH2 GCK TEK CHMP2A FAM83H KRT75 LMNA LMNB1 MAP1LC3C TTLL11 DNAH17 TMOD1 CEP295 RPL7 | 1.19e-03 | 1179 | 155 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT5 SPAST DNAH10 SYNE1 FBF1 DNAH2 GCK TEK CHMP2A FAM83H KRT75 LMNA LMNB1 MAP1LC3C TTLL11 DNAH17 TMOD1 CEP295 RPL7 | 1.28e-03 | 1187 | 155 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule organizing center | RAD18 RAPGEF6 SPAST FBF1 CNTRL UBR4 TSGA10 SPAG9 TEK SPDL1 FRY TTLL11 MAD1L1 CEP295 ATM CROCC | 1.34e-03 | 919 | 155 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.49e-03 | 8 | 155 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | centrosome | RAD18 RAPGEF6 SPAST FBF1 CNTRL UBR4 SPAG9 TEK SPDL1 FRY MAD1L1 CEP295 ATM CROCC | 1.81e-03 | 770 | 155 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | ubiquitin conjugating enzyme complex | 1.90e-03 | 9 | 155 | 2 | GO:0031371 | |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 INSYN1 IQSEC2 GRIK2 ITPR1 LIN7B IQSEC1 PLEKHA5 PLCB4 RPL7 | 2.02e-03 | 451 | 155 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | inner dynein arm | 2.36e-03 | 10 | 155 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.36e-03 | 10 | 155 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.57e-03 | 317 | 155 | 8 | GO:0032838 | |
| MousePheno | oligozoospermia | UBR2 RAPGEF6 DNAH10 DNAH2 SPAG9 CFAP54 LIPE UBE2B LMNA BRDT CBFA2T2 DNAH17 ICA1L ZMYM3 | 5.78e-06 | 384 | 121 | 14 | MP:0002687 |
| MousePheno | abnormal chromosome morphology | 1.34e-05 | 126 | 121 | 8 | MP:0003702 | |
| MousePheno | abnormal sperm number | UBR2 RAPGEF6 SPAST DNAH10 DNAH2 TSGA10 SPAG9 CFAP54 LIPE UBE2B LMNA BRDT CBFA2T2 DNAH17 ATM ICA1L ZMYM3 | 2.59e-05 | 624 | 121 | 17 | MP:0002673 |
| MousePheno | abnormal cell nucleus morphology | 3.11e-05 | 184 | 121 | 9 | MP:0003111 | |
| MousePheno | decreased male germ cell number | UBR2 RAD18 RAPGEF6 SPAST DNAH10 DNAH2 SPAG9 CFAP54 LIPE UBE2B LMNA BRDT CBFA2T2 DNAH17 ATM ICA1L ZMYM3 | 3.57e-05 | 640 | 121 | 17 | MP:0004901 |
| MousePheno | decreased germ cell number | UBR2 RAD18 RAPGEF6 SPAST DNAH10 DNAH2 SPAG9 CFAP54 LIPE UBE2B LMNA BRDT CBFA2T2 DNAH17 ATM ICA1L ZMYM3 | 8.59e-05 | 687 | 121 | 17 | MP:0002209 |
| MousePheno | abnormal chromosome number | 9.93e-05 | 86 | 121 | 6 | MP:0004023 | |
| MousePheno | dystrophic muscle | 1.59e-04 | 32 | 121 | 4 | MP:0000752 | |
| MousePheno | aneuploidy | 1.81e-04 | 61 | 121 | 5 | MP:0004024 | |
| Domain | Chemokine_XCL1/XCL2 | 6.32e-05 | 2 | 149 | 2 | IPR008105 | |
| Domain | KCC1 | 6.32e-05 | 2 | 149 | 2 | IPR000622 | |
| Domain | Grip | 7.83e-05 | 11 | 149 | 3 | SM00755 | |
| Domain | GRIP | 7.83e-05 | 11 | 149 | 3 | PF01465 | |
| Domain | Ran_BP1 | 1.04e-04 | 12 | 149 | 3 | PF00638 | |
| Domain | RANBD1 | 1.04e-04 | 12 | 149 | 3 | PS50196 | |
| Domain | GRIP_dom | 1.04e-04 | 12 | 149 | 3 | IPR000237 | |
| Domain | GRIP | 1.04e-04 | 12 | 149 | 3 | PS50913 | |
| Domain | RanBD | 1.34e-04 | 13 | 149 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.34e-04 | 13 | 149 | 3 | IPR000156 | |
| Domain | PDZ | 1.38e-04 | 141 | 149 | 7 | PF00595 | |
| Domain | AAA | 1.58e-04 | 144 | 149 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.58e-04 | 144 | 149 | 7 | IPR003593 | |
| Domain | PDZ | 1.87e-04 | 148 | 149 | 7 | SM00228 | |
| Domain | IQSEC_PH | 1.89e-04 | 3 | 149 | 2 | IPR033742 | |
| Domain | IQ_SEC7_PH | 1.89e-04 | 3 | 149 | 2 | PF16453 | |
| Domain | - | 2.03e-04 | 150 | 149 | 7 | 2.30.42.10 | |
| Domain | PDZ | 2.11e-04 | 151 | 149 | 7 | PS50106 | |
| Domain | PDZ | 2.20e-04 | 152 | 149 | 7 | IPR001478 | |
| Domain | TRPM_tetra | 3.75e-04 | 4 | 149 | 2 | PF16519 | |
| Domain | TRPM_tetra | 3.75e-04 | 4 | 149 | 2 | IPR032415 | |
| Domain | KCL_cotranspt | 3.75e-04 | 4 | 149 | 2 | IPR000076 | |
| Domain | TPR-like_helical_dom | 5.73e-04 | 233 | 149 | 8 | IPR011990 | |
| Domain | - | 6.22e-04 | 5 | 149 | 2 | 2.60.40.1260 | |
| Domain | Lamin_tail_dom | 6.22e-04 | 5 | 149 | 2 | IPR001322 | |
| Domain | LTD | 6.22e-04 | 5 | 149 | 2 | PF00932 | |
| Domain | PH_dom-like | ARHGAP42 RGPD8 IQSEC2 RGPD1 APBA2 PTPN4 IQSEC1 PLEKHA5 PLCB4 VASP RGPD5 | 6.30e-04 | 426 | 149 | 11 | IPR011993 |
| Domain | AAA | 7.82e-04 | 52 | 149 | 4 | PF00004 | |
| Domain | ATPase_AAA_core | 9.03e-04 | 54 | 149 | 4 | IPR003959 | |
| Domain | - | ARHGAP42 RGPD8 IQSEC2 RGPD1 APBA2 PTPN4 IQSEC1 PLEKHA5 PLCB4 VASP | 1.19e-03 | 391 | 149 | 10 | 2.30.29.30 |
| Domain | Rab_bind | 1.29e-03 | 7 | 149 | 2 | PF16704 | |
| Domain | ZnF_UBR1 | 1.29e-03 | 7 | 149 | 2 | SM00396 | |
| Domain | SLC12A_fam | 1.29e-03 | 7 | 149 | 2 | IPR004842 | |
| Domain | GCC2_Rab_bind | 1.29e-03 | 7 | 149 | 2 | IPR032023 | |
| Domain | ZF_UBR | 1.29e-03 | 7 | 149 | 2 | PS51157 | |
| Domain | zf-UBR | 1.29e-03 | 7 | 149 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.29e-03 | 7 | 149 | 2 | IPR003126 | |
| Domain | - | 1.38e-03 | 207 | 149 | 7 | 1.25.40.10 | |
| Domain | ATPase_AAA_CS | 1.56e-03 | 29 | 149 | 3 | IPR003960 | |
| Domain | Intermediate_filament_CS | 1.61e-03 | 63 | 149 | 4 | IPR018039 | |
| Domain | SLC12_C | 1.72e-03 | 8 | 149 | 2 | IPR018491 | |
| Domain | DHC_N1 | 1.72e-03 | 8 | 149 | 2 | PF08385 | |
| Domain | SLC12 | 1.72e-03 | 8 | 149 | 2 | PF03522 | |
| Domain | Dynein_heavy_dom-1 | 1.72e-03 | 8 | 149 | 2 | IPR013594 | |
| Domain | TPR_REGION | 2.11e-03 | 165 | 149 | 6 | PS50293 | |
| Domain | TPR | 2.11e-03 | 165 | 149 | 6 | PS50005 | |
| Domain | AAA | 2.48e-03 | 34 | 149 | 3 | PS00674 | |
| Domain | IQ | 2.50e-03 | 71 | 149 | 4 | PF00612 | |
| Domain | Filament | 2.50e-03 | 71 | 149 | 4 | SM01391 | |
| Domain | IF | 2.63e-03 | 72 | 149 | 4 | PS00226 | |
| Domain | CENP-B_N | 2.73e-03 | 10 | 149 | 2 | PF04218 | |
| Domain | - | 2.73e-03 | 10 | 149 | 2 | 1.10.220.60 | |
| Domain | Filament | 2.76e-03 | 73 | 149 | 4 | PF00038 | |
| Domain | IF | 3.20e-03 | 76 | 149 | 4 | IPR001664 | |
| Domain | FYVE_2 | 3.32e-03 | 11 | 149 | 2 | PF02318 | |
| Domain | HTH_Psq | 3.96e-03 | 12 | 149 | 2 | IPR007889 | |
| Domain | HTH_PSQ | 3.96e-03 | 12 | 149 | 2 | PS50960 | |
| Domain | RABBD | 3.96e-03 | 12 | 149 | 2 | PS50916 | |
| Domain | CENPB | 3.96e-03 | 12 | 149 | 2 | SM00674 | |
| Domain | Rab_BD | 3.96e-03 | 12 | 149 | 2 | IPR010911 | |
| Domain | DDE_1 | 3.96e-03 | 12 | 149 | 2 | PF03184 | |
| Domain | DDE_SF_endonuclease_dom | 3.96e-03 | 12 | 149 | 2 | IPR004875 | |
| Domain | HTH_CENPB | 4.65e-03 | 13 | 149 | 2 | PS51253 | |
| Domain | HTH_Tnp_Tc5 | 4.65e-03 | 13 | 149 | 2 | PF03221 | |
| Domain | HTH_CenpB_DNA-bd_dom | 4.65e-03 | 13 | 149 | 2 | IPR006600 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.40e-03 | 14 | 149 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.40e-03 | 14 | 149 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.40e-03 | 14 | 149 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.40e-03 | 14 | 149 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.40e-03 | 14 | 149 | 2 | IPR011704 | |
| Domain | MT | 5.40e-03 | 14 | 149 | 2 | PF12777 | |
| Domain | AAA_8 | 5.40e-03 | 14 | 149 | 2 | PF12780 | |
| Domain | AAA_5 | 5.40e-03 | 14 | 149 | 2 | PF07728 | |
| Domain | TPR_1 | 5.85e-03 | 90 | 149 | 4 | IPR001440 | |
| Domain | TPR_1 | 5.85e-03 | 90 | 149 | 4 | PF00515 | |
| Domain | IQ_motif_EF-hand-BS | 5.85e-03 | 90 | 149 | 4 | IPR000048 | |
| Domain | DHC_fam | 6.20e-03 | 15 | 149 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.20e-03 | 15 | 149 | 2 | PF03028 | |
| Domain | - | 6.20e-03 | 15 | 149 | 2 | 1.10.1000.11 | |
| Domain | Dynein_heavy_dom | 6.20e-03 | 15 | 149 | 2 | IPR004273 | |
| Domain | Sec7 | 6.20e-03 | 15 | 149 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 6.20e-03 | 15 | 149 | 2 | IPR023394 | |
| Domain | IQ | 6.56e-03 | 93 | 149 | 4 | PS50096 | |
| Domain | SEC7 | 7.05e-03 | 16 | 149 | 2 | PS50190 | |
| Domain | Sec7 | 7.05e-03 | 16 | 149 | 2 | SM00222 | |
| Domain | Sec7_dom | 7.05e-03 | 16 | 149 | 2 | IPR000904 | |
| Domain | TPR-contain_dom | 7.09e-03 | 150 | 149 | 5 | IPR013026 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | SPAST RGPD8 RGPD1 PSMC3 CHMP2A SPDL1 LMNA LMNB1 ANAPC1 MAD1L1 | 3.32e-05 | 234 | 121 | 10 | MM14898 |
| Pubmed | SLC12A6 KRT5 RGPD8 DTNA SYNE1 FBF1 CNTRL UBR4 GPS1 DNAH2 RGPD1 PRPF6 FAM98B ESF1 PPP1CB KRT75 LMNA SLC12A4 LMNB1 GLUD1 SMARCA1 CEP295 ATM RIMS2 IMMT RGPD5 | 1.47e-09 | 1442 | 156 | 26 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 RAD18 PDE4C RAPGEF6 SPAG9 CHD7 ATAD2 TFAP4 ESF1 PPP1CB YEATS2 LMNA ANAPC1 CBFA2T2 MAD1L1 IQSEC1 ATM ZMYM3 | 1.42e-08 | 774 | 156 | 18 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 UBR2 PDE3B RPH3AL DTNA ST7 ANXA6 UVSSA GRIK2 TFAP4 PPP1CB FBXO16 YEATS2 PTPN4 CBFA2T2 TTLL11 MAD1L1 PLCB4 TSC22D4 CAMTA1 CROCC ZSWIM4 CLEC16A ICA1L | 5.66e-08 | 1489 | 156 | 24 | 28611215 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RAD18 RGPD8 SYNE1 GPS1 RGPD1 SPAG9 PRPF6 NRIP3 GTF3C5 FAM83H ITPR1 PPP1CB ORC1 PHKA2 ACAD8 LMNB1 ANAPC1 MAD1L1 ATM ZMYM3 RGPD5 | 5.70e-08 | 1155 | 156 | 21 | 20360068 |
| Pubmed | The human RAD18 gene product interacts with HHR6A and HHR6B. | 8.85e-08 | 3 | 156 | 3 | 10908344 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 12509447 | ||
| Pubmed | UBE2A and UBE2B are recruited by an atypical E3 ligase module in UBR4. | 8.85e-08 | 3 | 156 | 3 | 38182926 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 10884424 | ||
| Pubmed | RAD18 CCDC137 MRS2 DTNA GPS1 LARS1 APBA2 PSMC3 MRPS16 FAM98B MCM10 GTF3C5 MRPL17 LMNA LMNB1 ANAPC1 BTBD7 TTLL11 SMARCA1 TMOD1 IMMT RPL7 | 1.47e-07 | 1335 | 156 | 22 | 29229926 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | LRSAM1 UBR4 LARS1 PSMC3 PRPF6 CHD7 MCM10 ATAD2 GTF3C5 ESF1 FAM83H PPP1CB BUD23 ORC1 LMNA LMNB1 SMARCA1 IQSEC1 PLEKHA5 IMMT RPL7 ZMYM3 | 1.85e-07 | 1353 | 156 | 22 | 29467282 |
| Pubmed | ANXA6 UBR4 PSMC3 SPAG9 PRPF6 CHD7 ATAD2 ESF1 PPP1CB LMNA ANAPC1 ATM IMMT RPL7 ZMYM3 | 2.85e-07 | 653 | 156 | 15 | 22586326 | |
| Pubmed | UBR2 SYNE1 YEATS2 MEGF8 ACOT11 BTBD7 CAMTA1 MAPKBP1 SYVN1 CROCC CLEC16A ZMYM3 | 3.47e-07 | 407 | 156 | 12 | 12693553 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12776193 | ||
| Pubmed | 3.65e-07 | 33 | 156 | 5 | 25582440 | ||
| Pubmed | RAPGEF6 RGPD8 UBR4 RGPD1 ZDBF2 CHD7 GTF3C5 SPDL1 YEATS2 ANAPC1 PLEKHA5 ZMYM3 | 4.60e-07 | 418 | 156 | 12 | 34709266 | |
| Pubmed | SOX6 SUPT3H RAD18 DNAH10 MRS2 DTNA UBR4 LARS1 RGPD1 PSMC3 MRPS16 SPAG9 CHD7 TFAP4 BUD23 MRPL17 YEATS2 RBM12 GLUD1 SMARCA1 IMMT ZMYM3 | 4.66e-07 | 1429 | 156 | 22 | 35140242 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 15359278 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 18363965 | ||
| Pubmed | TANC2 NCAPD3 ANXA6 FBF1 UBR4 DNAH2 RGPD1 ZDBF2 CHD7 GTF3C5 ESF1 YEATS2 MEGF8 CEP295 | 1.24e-06 | 638 | 156 | 14 | 31182584 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 NCAPD3 DNAH10 SYNE1 ANXA6 UBR4 LARS1 PSMC3 PRPF6 ATAD2 GTF3C5 ESF1 SPDL1 LMNA LMNB1 ANAPC1 GLUD1 SMARCA1 ATM IMMT RPL7 | 1.74e-06 | 1425 | 156 | 21 | 30948266 |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 15383616 | ||
| Pubmed | NBS1 recruits RAD18 via a RAD6-like domain and regulates Pol η-dependent translesion DNA synthesis. | 1.75e-06 | 6 | 156 | 3 | 21884979 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 21858012 | ||
| Pubmed | TANC2 SLC12A6 KRT5 SYNE1 IQSEC2 LARS1 PSMC3 FAM98B NDUFB7 JMY PPP1CB LMNA GLUD1 IQSEC1 SLC17A7 TMOD1 PLEKHA5 TSC22D4 CROCC IMMT RPL7 | 1.86e-06 | 1431 | 156 | 21 | 37142655 | |
| Pubmed | 1.92e-06 | 128 | 156 | 7 | 30995482 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.06e-06 | 7 | 156 | 3 | 15710750 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 21816346 | ||
| Pubmed | Silencing of unpaired chromatin and histone H2A ubiquitination in mammalian meiosis. | 3.06e-06 | 7 | 156 | 3 | 15657431 | |
| Pubmed | DTNA LRSAM1 PSMC3 MEGF8 CBFA2T2 MAD1L1 PLEKHA5 TSC22D4 MAPKBP1 SYVN1 IMMT ITPRIPL1 PDZD4 | 3.99e-06 | 608 | 156 | 13 | 16713569 | |
| Pubmed | 5.22e-06 | 210 | 156 | 8 | 16565220 | ||
| Pubmed | KRT5 NCAPD3 PDE3B ANXA6 CNTRL UBR4 PSMC3 PRPF6 CHMP2A ITPR1 CSGALNACT2 LMNB1 IQSEC1 PLEKHA5 SYVN1 IMMT RPL7 ITPRIPL1 | 5.54e-06 | 1168 | 156 | 18 | 19946888 | |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 5.91e-06 | 57 | 156 | 5 | 23080069 | |
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 26524528 | ||
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 1.04e-05 | 10 | 156 | 3 | 28533284 | |
| Pubmed | EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex. | 1.04e-05 | 10 | 156 | 3 | 24196706 | |
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 15579147 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.05e-05 | 231 | 156 | 8 | 16452087 | |
| Pubmed | Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. | 2.00e-05 | 2 | 156 | 2 | 8849694 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 2.00e-05 | 2 | 156 | 2 | 34031912 | |
| Pubmed | Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays. | 2.00e-05 | 2 | 156 | 2 | 21427063 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18524819 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15169909 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 17488709 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 11792809 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12556476 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35254895 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 9367621 | ||
| Pubmed | Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6. | 2.00e-05 | 2 | 156 | 2 | 1717990 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 1559696 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 20537150 | ||
| Pubmed | Requirement of Rad18 protein for replication through DNA lesions in mouse and human cells. | 2.00e-05 | 2 | 156 | 2 | 22547805 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 37229920 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21549715 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 11801724 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 9834111 | ||
| Pubmed | The NMR structure of the class I human ubiquitin-conjugating enzyme 2b. | 2.00e-05 | 2 | 156 | 2 | 11885984 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22528127 | ||
| Pubmed | Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. | 2.00e-05 | 2 | 156 | 2 | 25497737 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19097989 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18926833 | ||
| Pubmed | Defective prelamin A processing promotes unconventional necroptosis driven by nuclear RIPK1. | 2.00e-05 | 2 | 156 | 2 | 38538837 | |
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 2.00e-05 | 2 | 156 | 2 | 31835175 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25817592 | ||
| Pubmed | The differential expression of lamin epitopes during mouse spermatogenesis. | 2.00e-05 | 2 | 156 | 2 | 7680212 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 31683936 | ||
| Pubmed | Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. | 2.00e-05 | 2 | 156 | 2 | 9029087 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25343989 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 31413355 | ||
| Pubmed | The tail domain of lamin B1 is more strongly modulated by divalent cations than lamin A. | 2.00e-05 | 2 | 156 | 2 | 25807068 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19141474 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25353289 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 28806395 | ||
| Pubmed | Beta-strand-mediated dimeric formation of the Ig-like domains of human lamin A/C and B1. | 2.00e-05 | 2 | 156 | 2 | 33706103 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 32868078 | ||
| Pubmed | Differential regulation of Rad18 through Rad6-dependent mono- and polyubiquitination. | 2.00e-05 | 2 | 156 | 2 | 15509568 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12226740 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 3453101 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21156181 | ||
| Pubmed | Aberrant tissue positioning of metallophilic macrophages in the thymus of XCL1-deficient mice. | 2.00e-05 | 2 | 156 | 2 | 24778093 | |
| Pubmed | Protein-protein interactions between human nuclear lamins expressed in yeast. | 2.00e-05 | 2 | 156 | 2 | 7628545 | |
| Pubmed | Molecular cloning and functional characterization of human lymphotactin. | 2.00e-05 | 2 | 156 | 2 | 7602097 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 11818535 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 17510708 | ||
| Pubmed | Monomeric solution structure of the prototypical 'C' chemokine lymphotactin. | 2.00e-05 | 2 | 156 | 2 | 11601972 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24728176 | ||
| Pubmed | Concentration-dependent lamin assembly and its roles in the localization of other nuclear proteins. | 2.00e-05 | 2 | 156 | 2 | 24523288 | |
| Pubmed | Molecular cloning of a novel C or gamma type chemokine, SCM-1. | 2.00e-05 | 2 | 156 | 2 | 7875320 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 17990361 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22429593 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23850366 | ||
| Pubmed | DCM associated LMNA mutations cause distortions in lamina structure and assembly. | 2.00e-05 | 2 | 156 | 2 | 28844980 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 8757601 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 33570570 | ||
| Pubmed | RIP1 negatively regulates basal autophagic flux through TFEB to control sensitivity to apoptosis. | 2.00e-05 | 2 | 156 | 2 | 25908842 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30542351 | ||
| Pubmed | The role of cytokeratin 5/6 as an adjunct diagnostic tool in breast core needle biopsies. | 2.00e-05 | 2 | 156 | 2 | 18499686 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21584898 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 14734774 | ||
| Pubmed | β-Amyloid induces nuclear protease-mediated lamin fragmentation independent of caspase activation. | 2.00e-05 | 2 | 156 | 2 | 26876308 | |
| Pubmed | Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. | 2.00e-05 | 2 | 156 | 2 | 11181058 | |
| Cytoband | 17q25.3 | 4.05e-04 | 101 | 156 | 4 | 17q25.3 | |
| Cytoband | 6q16.3 | 4.07e-04 | 9 | 156 | 2 | 6q16.3 | |
| GeneFamily | PDZ domain containing | 3.76e-05 | 152 | 109 | 7 | 1220 | |
| GeneFamily | Lamins | 1.08e-04 | 3 | 109 | 2 | 612 | |
| GeneFamily | Dyneins, axonemal | 1.36e-04 | 17 | 109 | 3 | 536 | |
| GeneFamily | AAA ATPases | 2.92e-04 | 53 | 109 | 4 | 413 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.42e-04 | 7 | 109 | 2 | 785 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 2.69e-03 | 13 | 109 | 2 | 533 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX6 RAD18 SPAST DTNA CNTRL TSGA10 APLP1 GRIK2 ZDBF2 SPAG9 CHD7 FAM98B ESF1 SPDL1 LIN7B FBXO16 ORC1 PTPN4 CFAP54 RBM12 CEP295 PLCB4 ATM CAMTA1 CCDC40 | 1.25e-05 | 1370 | 151 | 25 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | ASK440-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.16e-07 | 186 | 156 | 8 | ce8e63057a99afa0a9cbf27ae7f9a70c0e972b6d | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.18e-07 | 193 | 156 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.88e-07 | 197 | 156 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Control-NK|World / Disease group and Cell class | 7.41e-07 | 143 | 156 | 7 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-06 | 173 | 156 | 7 | 0451450605521fecb27a958628870d268adfb023 | |
| ToppCell | Healthy_donor-NK_CD56bright|World / disease group, cell group and cell class (v2) | 4.58e-06 | 188 | 156 | 7 | 8ee359199c61c3b5b498ac35148390db5cc1a836 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.08e-06 | 191 | 156 | 7 | 2bd4ba4aaa0f4885079516156b409df527ab22f4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 191 | 156 | 7 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 193 | 156 | 7 | b53ffef20f918b7d1e9d3924562691d13245e2dd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-06 | 194 | 156 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / disease group, cell group and cell class | 6.02e-06 | 196 | 156 | 7 | 1bc1ec3351319c5d2daa0808cf161a7327e1758e | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-06 | 198 | 156 | 7 | 88bb764b21ca50e56f6c536a2d61d35afd8c3f36 | |
| ToppCell | Severe_COVID-19-T/NK-CD8+_T|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.43e-06 | 198 | 156 | 7 | 584f0dc6f22bb13956a5f6950698599e382907e9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.43e-06 | 198 | 156 | 7 | 4909a97c62702704a0327b9a2cd73f048c8afeb6 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.43e-06 | 198 | 156 | 7 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.43e-06 | 198 | 156 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.43e-06 | 198 | 156 | 7 | 2eb80255bacddbf778b1c9eec09f74b4cdb09b36 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.43e-06 | 198 | 156 | 7 | ec99da4e269c4cd982a395cdac0e4487ab14ec39 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.43e-06 | 198 | 156 | 7 | 06fdf8554148d11c0a946a7fd200edd9fa7e1965 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class | 6.87e-06 | 200 | 156 | 7 | 3ae0f3dc4f6c9e0315155de80967134b2c1b3364 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 200 | 156 | 7 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.87e-06 | 200 | 156 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 148 | 156 | 6 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 148 | 156 | 6 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 150 | 156 | 6 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 167 | 156 | 6 | 18e336faa2d2429ab49d1c6ae9bbf9923d74aa8d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 167 | 156 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.13e-05 | 171 | 156 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-05 | 173 | 156 | 6 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-05 | 175 | 156 | 6 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.30e-05 | 181 | 156 | 6 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-05 | 181 | 156 | 6 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.57e-05 | 183 | 156 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 4.71e-05 | 184 | 156 | 6 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.71e-05 | 184 | 156 | 6 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.86e-05 | 185 | 156 | 6 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.86e-05 | 185 | 156 | 6 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 185 | 156 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.86e-05 | 185 | 156 | 6 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.86e-05 | 185 | 156 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.86e-05 | 185 | 156 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.86e-05 | 185 | 156 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.86e-05 | 185 | 156 | 6 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.86e-05 | 185 | 156 | 6 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.00e-05 | 186 | 156 | 6 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 186 | 156 | 6 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 186 | 156 | 6 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 5.16e-05 | 187 | 156 | 6 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 187 | 156 | 6 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.16e-05 | 187 | 156 | 6 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 187 | 156 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 187 | 156 | 6 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.31e-05 | 188 | 156 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.47e-05 | 189 | 156 | 6 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.47e-05 | 189 | 156 | 6 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.47e-05 | 189 | 156 | 6 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 156 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Severe-Lymphoid-T-NK|Severe / Condition, Lineage, Cell class and cell subclass | 5.63e-05 | 190 | 156 | 6 | 60642de433f84fa2cecd796c3a1a4aab9219d3db | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.63e-05 | 190 | 156 | 6 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.63e-05 | 190 | 156 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 191 | 156 | 6 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.80e-05 | 191 | 156 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | critical-Lymphoid-CTL|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.97e-05 | 192 | 156 | 6 | 8c83050c1578d43ca0398ff920f30ea63f092a83 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-05 | 192 | 156 | 6 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.14e-05 | 193 | 156 | 6 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | Control-Lymphocyte-T_NK|Control / Disease, Lineage and Cell Type | 6.14e-05 | 193 | 156 | 6 | eb8b8f6e52fd140fbacf3d6776458c6fc355e120 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.14e-05 | 193 | 156 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 6.14e-05 | 193 | 156 | 6 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.32e-05 | 194 | 156 | 6 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.32e-05 | 194 | 156 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.32e-05 | 194 | 156 | 6 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.50e-05 | 195 | 156 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.50e-05 | 195 | 156 | 6 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.50e-05 | 195 | 156 | 6 | 4d7c2c4d0130c2d46877ff6dd4584525d8f74daf | |
| ToppCell | 343B-Lymphocytic-NK_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-05 | 195 | 156 | 6 | 33a460624a65ba033452c74d143089e0bfac8f3d | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 6.50e-05 | 195 | 156 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.50e-05 | 195 | 156 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 195 | 156 | 6 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | proximal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.50e-05 | 195 | 156 | 6 | 93093545bb23d2619ace029a52cffa1f673a0c2a | |
| ToppCell | proximal-Hematologic-Natural_Killer_T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.50e-05 | 195 | 156 | 6 | 3944e4800f5d904d4efa401ce8913ec0e0781211 | |
| ToppCell | LAM-Lymphoid-NK|LAM / Condition, Lineage and Cell class | 6.50e-05 | 195 | 156 | 6 | 229374c72acef32b0e915379bdf3c82f351940e2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.69e-05 | 196 | 156 | 6 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.69e-05 | 196 | 156 | 6 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 196 | 156 | 6 | 97ac47daf5bb07fa5dda3976e1ae402750f959b5 | |
| ToppCell | severe_influenza-CD8+_Tem|World / disease group, cell group and cell class (v2) | 6.69e-05 | 196 | 156 | 6 | 40fb254abcab2e65affc5d6037e71893a031d264 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-05 | 196 | 156 | 6 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-05 | 196 | 156 | 6 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.88e-05 | 197 | 156 | 6 | 48311c7d85ffabf59fd1685c31c18b3e84a145b5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.88e-05 | 197 | 156 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.09e-07 | 189 | 155 | 10 | 5248_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | DTNA ST7 CNTRL IQSEC2 TSGA10 APLP1 NPFFR1 LIN7B UBE2B CBFA2T2 | 1.04e-06 | 197 | 155 | 10 | 3355_DN |
| Drug | su-w | 3.06e-06 | 5 | 155 | 3 | CID000447612 | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 5.87e-06 | 188 | 155 | 9 | 3257_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 8.57e-06 | 197 | 155 | 9 | 6018_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 8.57e-06 | 197 | 155 | 9 | 6091_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 3326_DN | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 5684_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 9.30e-06 | 199 | 155 | 9 | 5412_UP | |
| Disease | survival time | 1.04e-05 | 9 | 149 | 3 | EFO_0000714 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.68e-05 | 12 | 149 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0070247 (implicated_via_orthology) | |
| Disease | lymphotactin measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0008214 | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 1.51e-04 | 4 | 149 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.51e-04 | 4 | 149 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.51e-04 | 5 | 149 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.51e-04 | 5 | 149 | 2 | C0410190 | |
| Disease | Familial partial lipodystrophy | 2.51e-04 | 5 | 149 | 2 | cv:C0271694 | |
| Disease | Epithelioid hemangioendothelioma | 2.51e-04 | 5 | 149 | 2 | C0206732 | |
| Disease | Emery-Dreifuss muscular dystrophy | 3.75e-04 | 6 | 149 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 3.75e-04 | 6 | 149 | 2 | C0410189 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 3.75e-04 | 6 | 149 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.18e-04 | 69 | 149 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Familial Partial Lipodystrophy, Type 3 | 5.23e-04 | 7 | 149 | 2 | C1720861 | |
| Disease | Familial Partial Lipodystrophy, Type 2 | 5.23e-04 | 7 | 149 | 2 | C1720860 | |
| Disease | Familial Partial Lipodystrophy, Type 1 | 5.23e-04 | 7 | 149 | 2 | C1720859 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.23e-04 | 7 | 149 | 2 | C0751337 | |
| Disease | Familial hyperinsulinism | 6.95e-04 | 8 | 149 | 2 | cv:C3888018 | |
| Disease | Familial partial lipodystrophy | 6.95e-04 | 8 | 149 | 2 | C0271694 | |
| Disease | hypoglycemia (is_implicated_in) | 6.95e-04 | 8 | 149 | 2 | DOID:9993 (is_implicated_in) | |
| Disease | progeria (implicated_via_orthology) | 6.95e-04 | 8 | 149 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 7.97e-04 | 36 | 149 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.67e-04 | 145 | 149 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | nephronophthisis (implicated_via_orthology) | 8.91e-04 | 9 | 149 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 9.35e-04 | 38 | 149 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.09e-03 | 40 | 149 | 3 | C0598589 | |
| Disease | Congenital small ears | 1.17e-03 | 41 | 149 | 3 | C0152423 | |
| Disease | Neurodevelopmental Disorders | 1.29e-03 | 93 | 149 | 4 | C1535926 | |
| Disease | Sepsis, mortality | 1.35e-03 | 11 | 149 | 2 | EFO_0004352, HP_0100806 | |
| Disease | hyperinsulinism (is_implicated_in) | 1.62e-03 | 12 | 149 | 2 | DOID:2018 (is_implicated_in) | |
| Disease | Bell's palsy | 1.81e-03 | 102 | 149 | 4 | EFO_0007167 | |
| Disease | psychosis | 2.21e-03 | 14 | 149 | 2 | EFO_0005407 | |
| Disease | Left ventricular noncompaction | 2.21e-03 | 14 | 149 | 2 | C1960469 | |
| Disease | plasminogen activator inhibitor 1 measurement | 2.59e-03 | 54 | 149 | 3 | EFO_0004792 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.90e-03 | 16 | 149 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.90e-03 | 16 | 149 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Monogenic diabetes | 2.90e-03 | 16 | 149 | 2 | C3888631 | |
| Disease | triacylglycerol 48:1 measurement | 3.28e-03 | 17 | 149 | 2 | EFO_0010404 | |
| Disease | uterine fibroid | 3.47e-03 | 199 | 149 | 5 | EFO_0000731 | |
| Disease | colorectal health | 3.62e-03 | 201 | 149 | 5 | EFO_0008460 | |
| Disease | FEV/FEC ratio | ARHGAP42 SLC26A9 SLC24A3 WWTR1 TFAP4 FAM83H ITPR1 PTPN4 UBE2A BRDT ANAPC1 TMOD1 CLEC16A PDZRN3 | 3.82e-03 | 1228 | 149 | 14 | EFO_0004713 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 4.01e-03 | 206 | 149 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | neck circumference | 4.09e-03 | 19 | 149 | 2 | EFO_0011043 | |
| Disease | cortical surface area change measurement, age at assessment | 4.09e-03 | 19 | 149 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 4.09e-03 | 19 | 149 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Fetal Growth Retardation | 4.53e-03 | 20 | 149 | 2 | C0015934 | |
| Disease | Adenocarcinoma of prostate | 4.53e-03 | 20 | 149 | 2 | C0007112 | |
| Disease | unipolar depression, mood disorder | 4.83e-03 | 134 | 149 | 4 | EFO_0003761, EFO_0004247 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 4.99e-03 | 21 | 149 | 2 | DOID:9884 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAENRKSSIIIRMRD | 76 | Q02325 | |
| RLREIMRSRQEMKNP | 66 | Q6PK04 | |
| YVRNSRMIDIQTRMA | 26 | O43709 | |
| MEIGRSAEMQQRIRS | 1401 | Q96N23 | |
| RMSILERLEQMERRM | 976 | Q9Y6Y1 | |
| LERRQMEISDAMRTL | 2146 | Q7Z7A1 | |
| DMATRLVAARLMVRN | 321 | Q9UKU7 | |
| EIRRARRMPMNKNEL | 261 | O43505 | |
| RRREAMVGTIDMTLQ | 921 | Q58F21 | |
| IQMERMRTVNAMAVR | 1261 | Q8IUA7 | |
| LRAKMDLEERRMRQI | 311 | P51693 | |
| MQRLAMDLRMLSREL | 1 | Q8WU67 | |
| KMEHSVAAERRRMRL | 171 | Q8WXI4 | |
| IVVLMARRRMPRSAS | 466 | Q99767 | |
| MCVLRMTRARRSQVE | 1291 | Q6PL18 | |
| MMSIRQRREIRATEV | 1 | Q6ZPD9 | |
| RQQMRQEALMKTDRR | 1926 | Q9P2D1 | |
| KRRNLMEMVAQLRES | 2416 | Q9P2D1 | |
| MDAVRIMAKDLVRTR | 56 | O43633 | |
| RIMVSRSELDMLDIR | 276 | P08133 | |
| KTEMQNMIELSRRRF | 76 | Q9NTZ6 | |
| TFEALKRNRMLMIQR | 356 | Q9NTZ6 | |
| KRNRMLMIQRYVEVS | 361 | Q9NTZ6 | |
| KEQRRRREFMMQSRL | 986 | Q9UPQ7 | |
| RDQRGLTALMKAAMR | 196 | Q7Z3H0 | |
| RMRLEASKLNESVMV | 311 | Q9NS91 | |
| RMLMRREQVLKVCAN | 1096 | Q99666 | |
| RMLMRREQVLKVCAN | 1096 | O14715 | |
| ERERIRQRMKMVIGQ | 21 | Q2T9L4 | |
| LDIVRTMRDQRAMMI | 881 | P29074 | |
| NRMRESRSEDVMRIT | 391 | P35557 | |
| KRFTRVEMARVLMER | 501 | O60271 | |
| IAMDQAIRRLGRREM | 1791 | Q9H1A4 | |
| EQMAKLMLQRAERRL | 386 | D6REC4 | |
| ASRRRARVVHMLVMV | 261 | Q9GZQ6 | |
| IYTLRNQEMKSAMRR | 286 | Q8NGI4 | |
| KFLQETMTEMARRNR | 231 | Q2VYF4 | |
| TMDRRKAATMRERRR | 81 | P13349 | |
| EMLRRVDAENRLQTM | 186 | P02545 | |
| MEARFEKMRSARRRQ | 181 | Q9HAP6 | |
| LTRRMREAEDMVQKV | 431 | Q9Y6D9 | |
| RELAMLRRQQIKISM | 391 | Q8N9B5 | |
| FQTLIQMMRSERDRM | 1361 | Q14643 | |
| RRRDVASAMQQMLTE | 381 | Q6UWE0 | |
| MSENRMSRRIVLSNM | 161 | Q6DN90 | |
| MSRRIVLSNMRMQFS | 166 | Q6DN90 | |
| ESRMSRRIILSNMRM | 376 | Q5JU85 | |
| RRIILSNMRMQFSFE | 381 | Q5JU85 | |
| ISEMNRMIQRLRAEI | 386 | P13647 | |
| VNSAREELMESRMRI | 286 | P20700 | |
| MSSKQEIMSDQRFRR | 1 | Q9H501 | |
| TRREMQSVVQLIMTR | 206 | Q9H501 | |
| MVEKTRRSMAVLRRC | 361 | O43439 | |
| IRAREQRKRREFMMQ | 686 | Q76G19 | |
| QRKRREFMMQSRLEC | 691 | Q76G19 | |
| MRRDERDAKAMRSLQ | 1 | Q13370 | |
| SAKQRLSLRRMVIDM | 481 | Q08493 | |
| FQRRAKAMMLRAAVL | 446 | Q13098 | |
| MERAMEQLNRLTRSL | 1 | Q8IYU2 | |
| EQRRHLQEMTKMASR | 2681 | Q7Z7M0 | |
| ITVRNNRIIMRMEYL | 126 | Q9HD23 | |
| VRDAMENEMRTQLRR | 471 | Q16891 | |
| KQRMLEMRRRKSEEI | 566 | Q7L590 | |
| SLRNKDVTRALRSMM | 296 | Q8NGX1 | |
| DVTRALRSMMQSRMN | 301 | Q8NGX1 | |
| SLRNKDVTRALRSMM | 296 | Q8NH03 | |
| DVTRALRSMMQSRMN | 301 | Q8NH03 | |
| MRLMKEVRGRNQTEV | 1 | Q8NGF4 | |
| NSRERKRMQDLNLAM | 111 | Q8TAK6 | |
| RTEIRMARMARKAGN | 66 | P18124 | |
| RSMQAKMLEQRRRLA | 21 | A8MYZ5 | |
| KTRLSMASRMLINER | 341 | Q9HC58 | |
| VMRMKEFERERRLLQ | 96 | P17568 | |
| DSRISMLRMDRPSRQ | 411 | Q9UQ26 | |
| MLRMDRPSRQRSISE | 416 | Q9UQ26 | |
| SPDLQSMEQIRRIMR | 176 | P62140 | |
| TVRVIRMKNVRQADM | 71 | Q3MJ16 | |
| MDLPERIMMNRVSSR | 656 | Q13415 | |
| SRQLEKRMSEEMRLL | 41 | Q6GPH6 | |
| IRARRKTARMLMIVL | 296 | O43614 | |
| QRTMLAVVDYMRRQK | 1906 | Q13315 | |
| LQEMSEKMRSLQERR | 86 | Q8N6G5 | |
| RRQMKMLDSENTRLG | 1286 | Q5TZA2 | |
| MERLRELQRASILDM | 691 | Q8TES7 | |
| MSVLRRMMRVSNRSL | 1 | Q9UBX8 | |
| ERMNILTNEMRRSLK | 4236 | Q9UFH2 | |
| RSARQIMRTAMKYNL | 516 | P00367 | |
| KMIRAMELAVARRET | 956 | Q4G0X9 | |
| RRRMLMKRLDVTVQS | 221 | Q52LJ0 | |
| MVEQTDLVRLRMVRM | 591 | Q9P203 | |
| RQEMVNLRATDVRLM | 101 | Q8IV03 | |
| RLSSEMTISMRQRLA | 731 | O60336 | |
| TMAERRQLFAEMRAQ | 11 | Q9Y4J8 | |
| RMSALQESRRELMVQ | 531 | Q9Y4J8 | |
| ELNMEIRDMIRRAQS | 2981 | Q5TBA9 | |
| DRTRLRKAQSMMSRR | 271 | Q8IX29 | |
| RRMIRSAQQVVAVVM | 141 | Q6ZRV2 | |
| MVEELRMSLKCQRRL | 861 | Q13002 | |
| LMTINRMEQARTEYR | 146 | Q8NDH6 | |
| ARIRMSARQKQIMEI | 501 | Q9C0D2 | |
| MTAVLNEMRRTNRLI | 1641 | Q8IVF4 | |
| LREDVVLMRALRDMN | 2026 | Q8IVF4 | |
| IRLDRMMEDALRLNV | 826 | Q9P225 | |
| QRSQMLRHMRLSKTE | 996 | Q9UHW9 | |
| ERSGINRLRSEMKQM | 996 | P46019 | |
| NRLRSEMKQMTRRFS | 1001 | P46019 | |
| MLDDSVMLARRLRNL | 996 | Q05469 | |
| IYTLRNQDMKAAMRR | 286 | Q15615 | |
| MTQFLSIIRSRMVLR | 66 | Q9BXW4 | |
| RLQKALDSVMSIREM | 381 | Q2NL67 | |
| RMLMRRDQVLKVCAN | 1081 | P0DJD0 | |
| RTMMLLAQMRRISLF | 36 | P05013 | |
| LVERLETMRRNVMGN | 76 | Q9UNE2 | |
| DMREAASLRQQRRMK | 16 | Q9NQ35 | |
| PMMITNAERLRRKRA | 101 | Q9Y3D3 | |
| DAIMSRRAIRNMNTL | 261 | Q86TM6 | |
| AVRRVVAAMNRMDQK | 681 | Q2YD98 | |
| MASRIGLRMQLMREQ | 1 | P19484 | |
| MQVDARMKRAERRIL | 266 | Q17RP2 | |
| RMISKEIRQVVRMTS | 1041 | Q8TEU7 | |
| TDTIRKEFRTRMVMN | 731 | Q15147 | |
| RLQKMGESSLRNFRM | 706 | P28370 | |
| RNICAMSMERRLKIE | 7981 | Q8NF91 | |
| PLSRRKAVDMRLRME | 231 | Q9Y3Q8 | |
| RMRPTQQRRSLFMKT | 576 | Q7LBE3 | |
| STRQEVERLMQRMKS | 241 | A6NI28 | |
| RKIGQARNTLMDMRL | 241 | O94906 | |
| DNCDSIIRRLMKMNR | 1091 | Q9P2J5 | |
| LQRKRTQQDRRMEME | 221 | A6NCM1 | |
| VEDRRAAMERQLISM | 261 | Q96EA4 | |
| ENLSMFLIKRRDMTR | 746 | Q9HCD6 | |
| RSRRIMSTTNVRKLM | 366 | Q9P2U7 | |
| CERARRLQAKMMTNL | 171 | Q9UBP0 | |
| ARRLGRTREAVKMMR | 306 | Q9NRC1 | |
| MAENRKSSIIIRMRD | 76 | P00747 | |
| LEEAKMMNRLRHSRV | 61 | Q13546 | |
| QRSQMLRQMRLTKTE | 931 | Q9UP95 | |
| KQLMRSRRQEMRQFF | 711 | P35712 | |
| CVMAMLRRRIRDEKT | 541 | P42695 | |
| GRIQARRMKMQRIAA | 811 | Q2KHT3 | |
| VRSMDRKSNTRNNMI | 81 | P47992 | |
| VRSMDRKSNTRNNMI | 81 | Q9UBD3 | |
| MVRKITLSRAVRTMQ | 281 | Q8NHH1 | |
| ERSHQIERMMSRIFR | 86 | Q6ZWK6 | |
| RMERAERQTRIMDSA | 166 | O75486 | |
| RGRAAMIQVLSREEM | 1761 | Q9BX84 | |
| PMNTRMIRKRNSLIA | 66 | Q96MW7 | |
| AMMNNNDLVRKRRLA | 331 | P28289 | |
| ARARIMQIHSRKMNV | 361 | P17980 | |
| MSTPARRRLMRDFKR | 1 | P49459 | |
| QRERMMTRLANKLRG | 2336 | Q9HCK1 | |
| VRGEAIRIRTMKMRQ | 106 | Q02763 | |
| IRIRTMKMRQQASFL | 111 | Q02763 | |
| RIRVTSERVENMSMR | 1181 | Q7Z4N2 | |
| AQEEITRLRREMMKS | 71 | Q9BZW7 | |
| SRDQRRKMALENPRM | 71 | Q05066 | |
| RKMALENPRMRNSEI | 76 | Q05066 | |
| ELRDTMSLMIRQTIR | 446 | Q9Y5Q8 | |
| TRPRMTVEEQMERIR | 896 | Q9HAU0 | |
| EIARLRREKIMAQMS | 1036 | Q8IWV8 | |
| MREEVRQLMCLLTRD | 3921 | Q5T4S7 | |
| RSVRMMLEEQVRSLE | 166 | Q01664 | |
| MSTPARRRLMRDFKR | 1 | P63146 | |
| RSMLESMLNRILAVR | 1341 | Q14202 | |
| QRLIEARRMMDKLRA | 66 | Q9ULM3 | |
| ARRMMDKLRACIVAN | 71 | Q9ULM3 | |
| RMLQIPNRSLDRAKM | 106 | Q9NRX2 | |
| RIRMRQEELMRQEAA | 246 | Q9GZV5 | |
| LMSTMRNQARLKVLR | 71 | Q96A05 | |
| EMNAMLARRRKATQV | 266 | P50552 | |
| LRSMFSKVREMLRMR | 281 | Q9H7M6 | |
| EISEMNRMIQRLRAE | 366 | O95678 |